Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study.

CONCLUSION: Intracameral bevacizumab during mitomycin C trabeculectomy in patients with primary open-angle glaucoma apparently does not improve success rates. The adjuvant use of intracameral bevacizumab is therefore not justified. PMID: 31496260 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31496260?dopt=Abstract

Source: European Journal of Ophthalmology - September 8, 2019 Category: Opthalmology Authors: Rabina G, Barequet D, Mimouni M, Kurtz S, Shemesh G, Rosenblatt A, Rosenfeld E Tags: Eur J Ophthalmol Source Type: research